Andre Goy Selected Research

Chromosome Deletion (Deletion, Chromosome)

1/2019

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andre Goy Research Topics

Disease

43	Neoplasms (Cancer) 11/2023 - 06/2003
34	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2023 - 06/2004
23	Lymphoma (Lymphomas) 11/2023 - 03/2003
22	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 03/2003
18	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 09/2003
12	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 03/2003
12	Hodgkin Disease (Hodgkin's Disease) 09/2023 - 07/2003
12	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 02/2005
11	Disease Progression 02/2023 - 11/2011
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020 - 03/2003
7	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 03/2004
4	Ovarian Neoplasms (Ovarian Cancer) 03/2016 - 11/2010
3	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2016 - 04/2013
3	Multiple Myeloma 10/2015 - 09/2012
2	Breast Neoplasms (Breast Cancer) 01/2023 - 06/2018
2	Fever (Fevers) 01/2022 - 01/2018
2	COVID-19 01/2021 - 01/2020
2	Body Weight (Weight, Body) 01/2020 - 12/2017
2	Leukemia 01/2019 - 12/2017
2	Tumor Lysis Syndrome 01/2019 - 01/2018
2	Fatigue 01/2018 - 11/2017
2	Cough 11/2017 - 10/2015
2	Neutropenia 02/2016 - 03/2006
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/2013 - 03/2011
2	Exanthema (Rash) 11/2011 - 08/2006
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 05/2004 - 06/2003
1	Residual Neoplasm 01/2023
1	Cytokine Release Syndrome 10/2022
1	Inflammation (Inflammations) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Chromosome Deletion (Deletion, Chromosome) 01/2019

Drug/Important Bio-Agent (IBA)

26	Rituximab (Mabthera)FDA Link 02/2023 - 07/2003
20	ibrutinibIBA 02/2023 - 08/2013
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2006
11	Chimeric Antigen ReceptorsIBA 11/2023 - 02/2015
10	Lenalidomide (CC 5013)FDA Link 09/2023 - 11/2011
10	Bortezomib (Velcade)FDA Link 01/2018 - 03/2004
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2003
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2003
8	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 08/2013
7	Bendamustine Hydrochloride FDA Link 10/2023 - 12/2014
7	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 09/2003
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 09/2003
6	axicabtagene ciloleucelIBA 11/2023 - 12/2017
6	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 09/2003
5	acalabrutinibIBA 07/2023 - 01/2018
5	venetoclaxIBA 06/2022 - 01/2018
5	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 06/2004
4	selinexorIBA 01/2022 - 07/2020
4	Immunoconjugates (Immunoconjugate)IBA 03/2017 - 08/2013
4	denileukin diftitox (Ontak)FDA Link 07/2013 - 10/2004
4	Proteasome InhibitorsIBA 09/2012 - 03/2004
3	brexucabtagene autoleucelIBA 10/2023 - 01/2020
3	Messenger RNA (mRNA)IBA 06/2018 - 12/2014
3	Brentuximab VedotinIBA 10/2016 - 08/2013
3	Prednisone (Sone)FDA LinkGeneric 12/2013 - 07/2013
2	AntibodiesIBA 01/2022 - 04/2004
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2020
2	Monoclonal AntibodiesIBA 01/2019 - 10/2015
2	Phosphotransferases (Kinase)IBA 01/2018 - 11/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 12/2013
2	obinutuzumabIBA 01/2017 - 10/2015
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2016 - 08/2013
2	Serine Proteases (Serine Protease)IBA 03/2016 - 12/2014
2	Syndecan-1 (Syndecan 1)IBA 10/2015 - 08/2013
2	Ifosfamide FDA LinkGeneric 07/2014 - 09/2003
2	Etoposide (VP 16)FDA LinkGeneric 07/2014 - 09/2003
2	Vinblastine (Vinblastine Sulfate)FDA Link 05/2012 - 11/2006
2	Bleomycin (Blenoxane)FDA LinkGeneric 05/2012 - 11/2006
2	Dacarbazine (DIC)FDA LinkGeneric 05/2012 - 11/2006
2	ibritumomab tiuxetan (Zevalin)FDA Link 02/2012 - 04/2004
2	pegfilgrastim (Neulasta)FDA Link 11/2006 - 03/2006
2	Anaplastic Lymphoma KinaseIBA 05/2004 - 06/2003
1	Tumor Biomarkers (Tumor Markers)IBA 05/2023
1	Cell-Free Nucleic AcidsIBA 05/2023
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	TabletsIBA 01/2022
1	Capsules (Microcapsules)IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	vistusertibIBA 11/2021
1	Therapeutic UsesIBA 01/2021
1	CD19 AntigensIBA 01/2021
1	C-Reactive ProteinIBA 01/2020
1	ChromatinIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	durvalumabIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	AnthracyclinesIBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 06/2018
1	Hormones (Hormone)IBA 06/2018
1	ProlactinIBA 06/2018

Therapy/Procedure

37	Therapeutics 11/2023 - 03/2004
17	Drug Therapy (Chemotherapy) 01/2020 - 09/2003
8	Stem Cell Transplantation 02/2023 - 07/2010
3	Precision Medicine 04/2017 - 10/2015
3	Aftercare (After-Treatment) 07/2012 - 10/2005
2	Salvage Therapy 01/2019 - 01/2017
1	Retreatment 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2020